Belite Bio, Inc. (BLTE)

159.85 +0.66 (+0.41%) USD  |  NASDAQ  |  Jan 22, 16:00
160.06 +0.21 (+0.13%) After-Hours: 20:00
More

Belite Bio Stock Based Compensation (Per Share Quarterly)

Stock Based Compensation (Per Share Quarterly) Chart

View Stock Based Compensation (Per Share Quarterly) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years

View Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Per Share Quarterly) Benchmarks

View Stock Based Compensation (Per Share Quarterly) Benchmarks
Start Trial
Ocugen, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
IDEAYA Biosciences, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade